Expert Advice 14 Mar 2023 5 reasons why collaboration is important in research …and speed up drug development, which is crucial when working towards developing successful treatments for a range of complex diseases. With regards to expertise, Linscott commented that the body of… March 14, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2022 Replay targets genetic brain disorders with new gene therapy company, Kaleibe …whose research at the University of Oxford focuses on the molecular mechanisms underlying neurodegenerative diseases, and Howard J Federoff, former distinguished Professor of Neurology at University of California, Irvine, and… December 14, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Sep 2023 Five biotech companies taking Los Angeles by storm …urticaria. Capsida Biotherapeutics Gene therapy platform company Capsida Biotherapeutics is working on the development of a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening diseases… September 19, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 25 Aug 2022 Evotec SE acquires highly-flexible drug manufacturing space for €1 …in depth – and with it the number of rare diseases that we can meaningfully distinguish and target with precision medicine. “Evotec DS reinforces our commitment to rare diseases by… August 25, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 20 Mar 2018 Why It’s the Best Time to Be in Cell and Gene Therapy …for diseases with short-term mortality, such as cancer. However, for more complex, chronic diseases such as diabetes, he expects “it will take a long time to get there.” With the… March 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 14 Apr 2023 20 years ago today: how genetic sequencing is changing lives since the Human Genome Project …and treatment in the fields of cancer, infectious diseases, rare and undiagnosed diseases, non-communicable diseases and pharmacogenomic diseases, all of which are important areas of research that can contribute to… April 14, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by WuXi Advanced Therapies 17 Jan 2023 Navigating cell and gene therapy manufacturing with a long-term partnership Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases, but developers face key challenges before these treatments reach patients’ bedsides. A long-term partnership with… January 17, 2023 - 7 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS …for the treatment of neurodegenerative diseases. 3P BioPharmaceuticals’ role will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be… November 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 19 Aug 2022 How re-engineering antibodies can prevent allergies …seeing in immunotherapies ushering in a new era of mobilizing immune cells to fight off diseases, such as cancers and autoimmune diseases, do you think it will be possible to… August 19, 2022 - 9 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2016 What Does ‘Anti-Aging Treatment’ Mean in Biotech? …it harder to advance treatments to prevent the diseases of aging. However, new strategies for turning promising aging science into medicines are beginning to emerge” Following leaps and bounds in… December 20, 2016 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2022 Eiger receives European approval for progeria treatment Eiger BioPharmaceuticals Inc., which focuses on the development of innovative therapies to treat and cure hepatitis delta virus and other serious diseases, has received marketing authorization from the European Commission… July 21, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Aug 2019 HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs …year to fund the development of antibodies tackling autoimmune diseases. Denmark-based Genmab raised an enormous €450M ($506M) to fund antibody drugs for cancer and autoimmune diseases when it entered the… August 29, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email